Diagnostic value of prostatic specific antigen in hirsute women

Journal of Endocrinological Investigation

Volumn 26, Issue 12, 2003, Pages 1198-1202

  Güllü, Sevim ^a   Emral, R ^a   Asik, M ^a   Cesur, M ^a   Tonyukuk, V ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Hirsutism; Polycystic ovary syndrome; Prostatic specific antigen

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AMENORRHEA; ANTIGEN DETECTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; HIRSUTISM; HUMAN; HYPERANDROGENISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PROGESTERONE BLOOD LEVEL; REGULATORY MECHANISM; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

EID: 1542376063     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349157     Document Type: Article

References (15)

1. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of PSA in serum as a screning test for prostate cancer. N Engl J Med 1991, 324: 1156-61.
2. Diamandis EP, Yu H. New biological functions prostate specific antigen? Clin Endocrinol Metab 1995, 80: 1515-7
3. Lilja H. Structure, function, and regulation of the enzyme activity of PSA. World J Urol 1993, 11: 188-91.
4. Diamandis EP, Yu H. Nonprostatic sources of PSA. Urol Clin North Am 1997, 24: 275-82.
5. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997, 82: 777-80.
6. Escobar-Morreale HF, Serrano-Gotarredona J, Avila S, Villar-Palasi J, Valrela C, Sancho J. The increased circulating PSA concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab 1998, 83: 2580-4.
7. Negri C, Tosi F, Dorizzi R, et al. Antiandrogen drugs lower serum PSA levels in hirsute subjects: Evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 2000, 85: 81-4.
8. Escobar-Morrealle HF, Avila S, Sancho J. Serum PSA concentrations are not useful for monitoring the treatment of hirsutism with oral contraseptive pills. J Clin Endocrinol Metab 2000, 85: 2488-92.
9. Hatch R, Rosenfield RL, Kiru MH, Tredway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol 1981, 140: 815-30.
10. Diamandis EP. PSA-new appliciations in breast and other cancers. Anticancer Res. 1996, 16: 3983-4.
11. Paulson RJ, Serafine PC, Catalino JA, Lobo RA. Measurement of 3-α, 17-β-androstenediol glucronide in serum and urine and the correlation with the skin 5-α reductase activity. Fertil Steril 1986, 46: 222.
12. Guess HA, Gormley GJ, Stoner E, Oesterling J. The effect of finasteride on prostate specific antigen: review of available data. J Urol 1996, 155: 3-9.
13. Fowler JE, Bigler SA, Renfroe DL, Dabagia MD. Prostate specific antigen in black and white men after hormonal therapies for prostate cancer. J Urol 1997, 158: 150-4.
14. Obiezu CV, Scorilas A, Magklara A, et al. Prostate-Specific Antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86: 1558-61.
15. Obiezu CV, Giltay EJ, Magklara A, et al. Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin Chem 2000, 46: 859-62.